DELTICOM-B2B
Users of Goodride, Star Performer or Nankang tyres will be more relaxed when it comes to their wallets in the future: Many of Delticom’s B2B shops now offer a lifetime warranty on its Star Performer tires and other Delticom house brands - giving its dealers strong selling points. The warranty is valid in Germany, Austria, Switzerland, Netherlands, Sweden, Denmark, France, Spain, Italy, Poland, Portugal and Finland. In the event of manufacturing or material defects and even irreparable damage due to everyday use the tire will either be replaced at no cost or big discounts will be offered. The compensation claim depends on the remaining tread depth. For example, defective tires with a remaining tread depth of six millimeters or more will be replaced with new ones, or customers receive a discount of up to 80 percent of the current price on the day the warranty claim is made.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181030005757/en/
"Current market monitors show a trend to increasing demand for cheap tires. Star Performer, Goodride and Nankang perfectly complement a dealer's portfolio", explains Thorsten Orbach, Head of Dealer Business at Delticom B2B. "Dealers can offer price-conscious end customers, who value an excellent cost benefit ratio above all else, an excellent alternative with an attractive margin for themselves at the same time. With the lifetime guarantee, we also generate business for our dealers with Goodride, Star Performer and Nankang tires.“
Additional information about the lifetime warranty can be found in the German online shop under the following links:
https://www.autoreifenonline.de/Goodride-Reifengarantie-lifetime.html
https://www.autoreifenonline.de/Star-Performer-Reifengarantie-lifetime.html
https://www.autoreifenonline.de/Nankang-Reifengarantie-lifetime.html
About Autoreifenonline.de
Autoreifenonline.de is the
exclusive German online shop for garages, dealers, wholesalers and
service/installation stations from Delticom AG with tires of all types
and car accessories. With more than 15 years experience in online tire
business, the B2B professional team from Autoreifenonline.de offers
their business customers an outstanding range of car and motorcycle
tires of all makes and sizes for all vehicle types, light truck and
truck tires, bus tires, special tires, complete wheels, car spare parts
and accessories, engine oil and batteries. Dealers not only benefit from
good purchasing conditions, but also time-saving tire search functions
in the online shop, high availability, reliable delivery thanks to their
own warehouses, as well as easy registration and use without any hidden
costs - from the very first tire on.
Online shops for dealers and garages in Germany, Austria and Switzerland : www.autoreifenonline.de , www.autoreifenonline.at , www.autoreifenonline.ch and 24 other countries.
Information about the business : www.delti.com
Tire tests : www.reifentest.com
The original source-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the source-language text, which is the only version of the text intended to have legal effect.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181030005757/en/
Contact:
Press contact insignis Agentur für Kommunikation GmbH (GPRA) Henning Jahns Tel.: +49-511-132214-14 Fax: +49-511-132214-99 delticom@insignis.de or Delticom AG Anne Lena Peters Tel.: +49-511-93634-8909 Fax: +49-511-93634-8301 anne.lena.peters@delti.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ICD 2025: New data demonstrate Nemluvio®’s (nemolizumab) favorable safety profile and sustained and clinically meaningful improvements in symptoms of prurigo nodularis up to two years18.6.2025 07:00:00 CEST | Press release
An interim analysis of the OLYMPIA long-term extension study to be presented as a late-breaking abstract at the XIV International Congress of Dermatology (ICD) found that Nemluvio was well tolerated and associated with sustained and clinically meaningful improvements in the key signs and symptoms of prurigo nodularis, including both skin lesions and itch, up to two years1 Results build on data from OLYMPIA – the largest completed pivotal clinical program in prurigo nodularis and the only one assessing long-term safety and efficacy in prurigo nodularis1-3 This follows the presentation of data from the ARCADIA long-term extension study at the Revolutionizing Atopic Dermatitis (RAD) Conference earlier this month, which showed Nemluvio is well tolerated with sustained and increased improvements in efficacy outcomes in atopic dermatitis patients up to two years4 Galderma (SIX: GALD) today announced data from a new interim analysis of a study investigating the long-term safety and efficacy o
LabPMM® Receives New York State Approval for the NPM1 MRD Assay - Informing Therapy and Accelerating Targeted Trials18.6.2025 06:30:00 CEST | Press release
Invivoscribe is happy to announce that its wholly owned subsidiary, the Laboratory for Personalized Molecular Medicine® (LabPMM) has received approval from New York State (NYS) for the NPM1 MRD Assay. This approval comes just two months after gaining NYS approval for our FLT3 ITD MRD Assay. Together these tests represent a critical tool for patients with acute myeloid leukemia (AML), clinicians and pharmaceutical companies. This new approval underscores Invivoscribe’s ongoing commitment to providing the most accurate, standardized measurable residual disease (MRD) testing solutions worldwide. The NPM1 MRD Assay is a pivotal development in the fight against AML, offering an ultra-sensitive DNA sequencing method to accurately measure trace levels of residual leukemia cells in patients with the NPM1 mutation variants. NPM1 mutations are considered an ideal target for MRD assessment because they are present in ~30% of adult AML cases,1 stable over time,2 and, if present in blood at allele
DNP to Take Controlling-Stake in Laxton18.6.2025 03:30:00 CEST | Press release
Maximizing synergies to accelerate the global expansion of biometric info-driven government authentication and security business Dai Nippon Printing Co., Ltd. (DNP, TOKYO: 7912) entered into a share transfer agreement on June 17, 2025 to acquire Cayman Islands-headquartered Rubicon SEZC. Rubicon (a holding company of “Laxton” group) is a global Identity Systems Integrator that provides ID solutions for governments, primarily in developing nations, to register and authenticate personal information. DNP plans to acquire 75% of Rubicon's shares in July and complete the procedures to make the company a Group company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250613922077/en/ Products of Laxton DNP will maximize synergies with Laxton in ID cards and card printers. By expanding to government-related business in Africa, Asia, South America, and other regions, we will further grow our authentication and security business, contr
DNP: Operational Launch of 2,500 mm-Width Coating Line to Enhance Production Capacity by 15%18.6.2025 03:20:00 CEST | Press release
- To accommodate large-scale TVs and high-end model demands - Dai Nippon Printing Co., Ltd. (DNP) is pleased to announce the September operational launch of a coating device compatible with 2,500 mm-width high functional optical film at our Mihara Plant in Hiroshima Prefecture. The operational launch of the second wide coating device comes in response to market and consumer needs, and will boost production capacity by more than 15% on an area basis. With the increased capacity, DNP will accommodate the demand for high functional optical film for 65-inch large-screen TVs, with horizontal and vertical dimensions of 1,436.4 mm x 809.0 mm, which are expected to increase at a compound annual growth rate (CAGR) of approximately 6% between 2025 and 20301 on an area basis. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250613720341/en/ Image of Mihara Plant [Features] Facilitates the efficient manufacture, or imposition, of high fun
Alipay Enables In-Store Payment Functionality in China for AR Glasses in Collaboration with Rokid to Build Immersive Commerce18.6.2025 02:27:00 CEST | Press release
Over 250,000 units of Rokid Glasses have already been ordered, integrated with Alipay’s digital payment technology for AR glasses.The integration of payments into AR glasses supports a future of seamless, intuitive commerce—enabling instant, gesture-based transactions, immersive product discovery, and new ways for businesses to engage customers. Rokid, a pioneer in augmented reality (AR), today launched Rokid Glasses, its latest AR device. In China, the product supports in-store payments facilitated by Alipay’s digital payment technology and multidimensional risk control solution for AR glasses, providing a seamless and secure payment experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250617845457/en/ Rokid partners with Alipay to launch China’s first AR glasses with in-store payment capabilities. According to Rokid, the product will begin rolling out to users starting in June 2025, with over 250,000 units already or
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom